Back to results
US 9,776,977 B2Granted
PSMA-targeting compounds and uses thereof
AssigneeThe Johns Hopkins University
InventorsMartin G. Pomper, Ronnie C. Mease, Sangeeta Ray
Life of this patent
Estimating the term…
Abstract
Prostate-specific membrane antigen (PSMA) targeting compounds are described. Uses of the compounds for imaging, therapy, cell sorting, and tumor mapping are also described.
Claims7
A compound having the following chemical structure:
- wherein Z is tetrazole or CO2Q;
- wherein each Q is independently selected from hydrogen or a protecting group, wherein the protecting group is selected from the group consisting of benzyl, p-methoxybenzyl, tertiary butyl, methoxymethyl, methoxyethoxymethyl, methylthiomethyl, tetrahydropyranyl, tetrahydrofuranyl, benzyloxymethyl, trimethylsilyl, triethylsilyl, t-butyldimethylsilyl, and triphenylmethyl;
- a is 1, 2, 3, or 4;
- R is each independently H or C1-C4 alkyl;
- Y is —C(O)—;
- V is —C(O)— or —NRC(S)—;
- m is 1, 2, 3, 4, 5, or 6;
- n is 1, 2, 3, 4, 5 or 6;
- p is 0, 1, 2, or 3, and when p is 2 or 3, each R1 may be the same or different;
- R1 is H, C1-C6 alkyl, C2-C12 aryl, or C4-C16 alkylaryl
- R2 and R3 are independently H, CO2H, or CO2R4, where R4 is a C1-C6 alkyl, C2-C12 aryl, or C4-C16 alkylaryl, wherein when one of R2 and R3 is CO2H or CO2R4, the other is H, and when p is 0, one of R2 and R3 is CO2R4, and the other is H;
- and
- Ch is a chelating moiety, optionally including a chelated metal, wherein the chelating moiety is selected from the group consisting of:
- and wherein + is the bond connecting the chelating moiety to the rest of the molecule.
11 more elements
Dependencies are inferred from the claim text.